Technology Transfer Office
Search

CYTOO

Institut Curie
02/03/2021
Share
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. The company partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.
Cytoo

CYTOO is a company specialized in target discovery and selection of therapeutic candidates for the treatment of muscle and neuromuscular disorders. The company partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.

Cytoo

 

 

Year of creation: 2008

Line of business: CRO

Institut Curie: Behind the technology and institutional co-founder

 

TECHNOLOGY

CYTOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.

 

APPLICATIONS

Biotechnologies & Pharmaceuticals.

External partners
La Financière du Faouet

Investor

CGSE Compagnie

Investor